Easton Pharmaceuticals, Inc. (EAPH)

[wjb007]

iBliss could not prove its worth, or they are history: Easton and iBliss Inc. executed an agreement for the 100% acquisition of iBliss by Easton. Subsequent to the June 30th quarter, Easton issued 218,000,000 shares to iBliss and its subscribers, which are to be held in escrow to be conditionally released as per milestone revenues as stated in its agreement. The agreement was being amended to restructure minor provisions of the agreement that did not require any cash payments which would then result in the release of the shares from escrow, at which time, Easton will consolidate iBliss revenues into its own financial statements. Should iBliss not meet revenue milestones or renegotiated, the agreement and the transaction will be terminated.